"Pharmacyclics has enjoyed a long association with Integral Capital Partners (ICP).
They began following our company at a very early stage and led an important venture
financing round. Once involved in our company, they played a vital role in assisting
us with some key business and financial strategic matters. They participated in our
IPO and have remained shareholders since their venture-stage investment over five years ago.
The periodic contacts that I receive from ICP requesting updates on Pharmacyclics are always welcome.
These meetings tend to be two-way dialogs and are a valuable way for me, as CEO, to get the
knowledge and experience of astute investors such as John Powell and Roger McNamee.
I have been significantly influenced by their recommendations and observations.
I consider ICP an investor with a long-term stake in our success and we feel privileged
to have them involved in building our company."
